1. james calfee james calfee United States says:

    Sorry that is making life hard for the FDA.  I studied this quite a bit.  

    Despite that,  I'm happy this is getting a lot of attention even if it is the wrong kind.  This is important, especially in the area of Parkinson's where the conventional treatment is known to worsen the disability and can in it-self cause death.  

    So, I have to ask everyone to consider this.  I'm saying: yea, but it works!  I proved it to myself then I started the treatment.  In these cases, way better than the conventional drug alternatives.  I know it when I see it, there is something here.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.